United States · FDA National Drug Code directory
Pirfenidone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-479_9f41a23e-cc34-4b25-871d-deeef997fe8d
- Product NDC
- 62332-479
- Form
- TABLET, COATED
- Composition / generic term
- Pirfenidone
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220610
- Source listing expiry
- 20261231
Source-listed ingredients
- PIRFENIDONE — 267 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 270 TABLET, COATED in 1 BOTTLE (62332-479-27) · 62332-479-27
- 3 BOTTLE in 1 CARTON (62332-479-64) / 90 TABLET, COATED in 1 BOTTLE · 62332-479-64
- 500 TABLET, COATED in 1 BOTTLE (62332-479-71) · 62332-479-71
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →